Alaskan Cod Liver Oil Natural Lemon Flavor
Goals
$59.97 $1.24 per serving
Product analysis
Alaskan Cod Liver Oil Natural Lemon Flavor provides nutrients relevant to skin health and may modestly support joint comfort. The high cost for the omega-3 fatty acids provided limits its value.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality21
Most ingredient forms are unspecified, limiting comparisons of absorption and quality. The quality of the remaining identified components also remains uncertain.
Ingredient Transparency54
All listed amounts are stated, allowing quantity comparisons. Most forms and some fatty-acid composition details are missing, limiting a closer comparison.
Value For Money32
The cost is high for the omega-3 fatty acids provided. Value for the other assessed components remains uncertain.
Customer Satisfaction73
Customer ratings are very positive, with a modest number of reviews. That offers some insight into satisfaction without establishing health benefits.
Product Focus64
Omega-3 and vitamin A contribute to normal skin nutrition, while omega-3 may provide modest joint-comfort support. A dependable increase in everyday calorie burning is not established.
- Format
Liquid - Container
- 8 Fluid Ounce(s)
- Per serving
- $1.24
- Customer rating
- 4.8 · 102 ratings
Goals
Impact
High effect
Omega-3 · 1000 mg
Omega-3 supplies fatty acids relevant to barrier lipids, while vitamin A supports normal skin-cell development. Barrier support is the main saved finding, with a smaller structural contribution. Generic omega-3 cannot inherit findings from specific purified EPA preparations, and vitamin A supplement amounts do not establish prescription retinoid-like cosmetic effects.
How this product is rated for Skin Health
Ingredient fit77
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
Relevant skin nutrients sit within a broader formula containing ingredients without an established role for this goal.
Dose adequacy
The disclosed amounts provide partial support; smaller or unresolved quantities limit the amount finding.
Pathways50
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Depth
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Breadth
One skin mechanism reaches the coverage threshold; support across other mechanisms remains limited.
Evidence78
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Impact
Moderate effect
Omega-3 · 1000 mg
EPA at 600 mg and DHA at 340 mg are relevant to inflammatory processes associated with joint discomfort. Evidence for repeated omega-3 intake is mixed, with some modest adult symptom benefits; the small vitamin D serving has a separate nutritional role.
How this product is rated for Joint Health
Ingredient fit63
Joint-related ingredients share the formula with ingredients aimed at other health needs. The included amounts provide partial support against the saved dose benchmarks.
Goal fit
Joint-related ingredients share the formula with ingredients aimed at other health needs.
Dose adequacy
The included amounts provide partial support against the saved dose benchmarks.
Pathways16
The strongest saved finding concerns inflammation-related support. None of the three target mechanisms reaches the saved coverage threshold.
Depth
The strongest saved finding concerns inflammation-related support.
Breadth
None of the three target mechanisms reaches the saved coverage threshold.
Evidence69
Omega-3 provides the strongest saved evidence rating, with modest benefits in some trials and null findings in others. The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Evidence strength
Omega-3 provides the strongest saved evidence rating, with modest benefits in some trials and null findings in others.
Studied preparation
The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Formulation logic100
No required ingredient partner is missing in the saved findings. No configured ingredient conflict was found in the saved assessment. All ingredients included in this finding reach the saved minimum dose threshold.
Partner coverage
No required ingredient partner is missing in the saved findings.
Conflicts
No configured ingredient conflict was found in the saved assessment.
Effective doses
All ingredients included in this finding reach the saved minimum dose threshold.
Impact
Moderate effect
Omega-3 · 1000 mgVitamin D · 5 mcg
Whether omega-3 raises your resting calorie use is unclear for adults in general. Possible effects have varied between different groups of people, so they don't translate into a dependable metabolism boost from this serving. Changes in insulin-related processes are also different from an increase in whole-body energy expenditure.
How this product is rated for Metabolism Support
Ingredient fit55
Omega-3 has an uncertain effect on resting energy use across adults.
Goal fit
Omega-3 has an uncertain effect on resting energy use across adults.
Dose adequacy
The serving provides Omega-3 1000 mg, Vitamin D 5 mcg. These amounts alone don't predict an increase in calorie burning.
Pathways18
The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Depth
The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Breadth
The connection is limited to stimulation of energy use, rather than several distinct effects on calorie burning.
Evidence89
Omega-3 has an uncertain effect on resting energy use across adults.
Evidence strength
Omega-3 has an uncertain effect on resting energy use across adults.
Studied preparation
The declared ingredient forms match the relevant preparation descriptions; this alone does not predict the size of a benefit.
Formulation logic100
No particular ingredient conflict or missing required partner is identified.
Partner coverage
No required companion ingredient is missing for the ingredient roles described here.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The declared serving amounts are available for comparison; that does not make them minimum effective doses for increasing calorie burning.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 45 Calorie(s) | |
Total Fat | 5 Gram(s) | |
Cholesterol | 30 mg | |
Protein | 2 Gram(s) | |
Vitamin A | 1100 mcg | |
Vitamin D | 5 mcg | |
Total Omega-3 Fatty Acids | 1000 mg | |
Total Pro-Resolving Mediators (14-HDHA, 17-HDHA, 18-HEPE) | 175 mcg |
Omega-3 · 1000 mg OverallScore61
A serving provides 600 mg EPA and 340 mg DHA in triglyceride form. Combined EPA and DHA cost about $1.33 per gram.
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
Cod liver omega-3 is described as triglycerides; antioxidant protection is not established by the saved facts.
Molecular Form & Absorption Potential
The omega-3 oil is described as being in triglyceride form.
Source Purity & Oxidative Protection
Cod liver oil is the source; the saved facts do not establish antioxidant protection.
Dose, Safety & Label Transparency70
EPA and DHA are listed separately, but their concentration in the source oil cannot be established from the saved facts. A qualifying certification claim is recorded.
EPA & DHA Label Specificity
The serving lists 600 mg EPA and 340 mg DHA separately.
Active Ingredient Concentration
The oil amount needed to determine the EPA and DHA concentration is not available in the saved facts.
Third-Party Purity Verification
A qualifying certification claim is recorded, but its name and independent verification are not supplied in the saved facts.
Value20
A whole-product serving costs about $1.25, or $1.33 per gram of EPA and DHA combined.
Price per 1000mg of EPA+DHA
The estimated cost is $1.33 per 1,000 mg of combined EPA and DHA.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
- Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
- Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
- Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
- Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis.
- Vitamin D Deficiency Leads to Poorer Health Outcomes and Greater Length of Stay After Total Knee Arthroplasty and Supplementation Improves Outcomes: A Systematic Review and Meta-Analysis.
- Does vitamin D improve symptomatic and structural outcomes in knee osteoarthritis? A systematic review and meta-analysis.
- Baseline 25-hydroxyvitamin D levels predict the effects of vitamin D supplementation on joint symptoms and cartilage loss in patients with knee osteoarthritis.
- The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.
- Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
- Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
- Effects of vitamin D supplementation on insulin resistance and lipid metabolic profiles in women with gestational diabetes mellitus: A randomized controlled trial.
- Vitamin D3 improves glucose metabolism and attenuates inflammation in prediabetic human and mice.
- Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.
- The Effects of Vitamin D Supplementation on Glycemic Control, Lipid Profiles and C-Reactive Protein Among Patients with Cardiovascular Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis.